Cannabis Report
Home > Boards > US OTC > Biotechs >

PharmaCyte Biotech Inc. (PMCB)

Add PMCB Price Alert      Hide Sticky   Hide Intro
Moderator: mick, Hunchbackgeek, $Pistol Pete$, thenewmixer, fraum, concordia
Search This Board: 
Last Post: 6/17/2018 3:40:26 PM - Followers: 797 - Board type: Free - Posts Today: 0

Welcome to PharmaCyte BioTech
An OTCQB Company  



PharmaCyte is a clinical stage biotechnology company developing therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as "Cell-in-a-Box." This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed. For cancer, the therapy involves encapsulating genetically engineered human cells that convert the prodrug ifosfamide from its inactive form to its "cancer" killing form. These encapsulated live cells are implanted in a patient as close to the tumor as possible. Then ifosfamide is given IV at one-third the normal dose. When the ifosfamide comes in contact with the encapsulated live cells, they act as an artificial liver (where ifosfamide is normally activated) and activate the ifosfamide at the source of the cancer. For diabetes, PharmaCyte is developing a treatment for Type 1 diabetes and insulin-dependent Type 2 diabetes. PharmaCyte plans to encapsulate a human cell line that has been genetically engineered to produce, store and release insulin in response to the levels of blood sugar in the human body. The encapsulation will be done using the Cell-in-a-Box technology. Once the encapsulated cells are implanted in a diabetic patient they will function as a "bio-artificial pancreas" for purposes of insulin production.


FDA Grants Orphan Drug Designation to Pharmacyte Biotech for Pancreatic Cancer Treatment

European Medicines Agency (EMA), the European Commission has granted the Orphan Drug designation to PharmaCyte’s subsidiary,
PharmaCyte Biotech Europe Limited, for PharmaCyte’s pancreatic cancer treatment

 Company Address
PharmaCyte Biotech, Inc.

23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92652
Office Number: 917.595.2850
Facsimile Number: 917.595.2851

Market Value:
$122,386,272 a/o Dec 19, 2016

Shares Outstanding:
848,904,665 a/o Aug 29, 2016

Authorized Shares:
1,490,000,000 a/o Aug 26, 2014

817,204,665 a/o Aug 29, 2016

For more updated information please visit:

Transfer Agent:
Signature  Stock Transfer Inc. Plano TX  Ph # 972-612-4120

Investor Relations

Stonegate Capital Inc.
8201 Preston Road
Suite 325
Dallas, TX 75225
United States


   All News Releases:


What is Cell-in-a-Box®?

The Cell-in-a-Box® technology, developed by Austrianova, is a means to protect, isolate, storeand transport living cells. The proprietary technology can be used for a variety of purposes.
In healthcare, it facilitates the safe implantation of cells, holding them isolated from the immune system and allowing long term production of therapeutic molecules in patients. 
In biotechnology, the Cell-in-a-Box® technology protects cells in bioreactors and fermenters, while at the same time simplifying purification of bioproducts produced from the cells and reducing production cost. 
The technology can also be applied to probiotics, cosmetics and agriculture, environmental protection and monitoring, as well as forming the basis of a powerful research tool. 
The company’s proprietary cell packaging material, Gel8, used for the Cell-in-a-Box® technology, is derived from a naturally occurring material and is thus harmless to the environment, biologically inert and has been shown to be safe in humans. 

Management Team:

Kenneth L. Waggoner, Chief Executive Officer and President

Gerald W. Crabtree, Ph.D. – Chief Operating Officer and Director

Carlos A. Trujillo – Chief Financial Officer and Director

Walter H. Gunzburg – Chief Scientific Officer

Dr. Matthias Lohr as Chairman of Scientific Advisory Board

Thomas Liquard - Chairman of the Audit Committe

  Dr. Eva Maria (Lilli) Brandtner – Director of Diabetes Program Development

Dr. Manuel Hidalgo, Scientific Advisory Board





-  The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
-  We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
-  There are no guarantees when buying or selling any security.



Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PMCB News: Current Report Filing (8-k) 05/15/2018 07:01:33 AM
PMCB News: Quarterly Report (10-q) 03/19/2018 04:41:09 PM
PMCB News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 02/22/2018 04:30:00 PM
PMCB News: Current Report Filing (8-k) 02/22/2018 04:26:40 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#83679  Sticky Note $PMCB PharmaCyte’s Clinical Trial in Pancreatic Cancer S $Pistol Pete$ 06/06/18 01:45:44 PM
#81636  Sticky Note Jun 6, 2011 Nuvilex, Inc. Readies Pancreatic Cancer concordia 03/09/18 09:34:06 AM
#80476  Sticky Note PMCBs CC thenewmixer 01/30/18 01:43:58 PM
#80354  Sticky Note $PMCB A Must Watch Video PMCB $Pistol Pete$ 01/24/18 05:30:46 PM
#79557  Sticky Note HUGE READ MY FRIEND/ PHARMACYTE BIOTECH/ $PMCB/ STAY mick 01/10/18 10:06:32 AM
#84415   If the IND is approved and I heard hockeypond 06/17/18 03:40:26 PM
#84414   1234 I’m sure he meant along side the PINKribbon 06/17/18 01:52:26 PM
#84413   They need the strength skills and finances of 1234jklm 06/17/18 01:46:35 PM
#84412   I totally agree.I get the feeling they are ambitious1 06/17/18 12:13:59 PM
#84411   Exactly Go PMCB!!! The Promised Land 06/17/18 11:37:36 AM
#84410   Happy Fathers Day guys! :) :) :) PINKribbon 06/17/18 10:26:20 AM
#84409   I agree, especially being involved with a development PINKribbon 06/17/18 10:22:48 AM
#84408   Most of these people care more about what Pmcbinv 06/17/18 09:02:51 AM
#84407   They certainly might see it through a diabetes Pmcbinv 06/17/18 08:53:18 AM
#84406   They got it to this point in their Pmcbinv 06/17/18 08:48:45 AM
#84405   The CEO is 75 1234jklm 06/17/18 12:19:52 AM
#84404   Right so! purplehp 06/16/18 08:34:40 PM
#84403   It is easy, why reinvent the wheel? Take purplehp 06/16/18 08:28:38 PM
#84402   You gotta love the USPTO!!! ...right? ;) PINKribbon 06/16/18 08:27:07 PM
#84401   Personally, I’ve always excepted and understood there would PINKribbon 06/16/18 08:25:32 PM
#84400   It just fascinates me how it seems that Runuvi 06/16/18 08:20:36 PM
#84399   If it is not the black market... purplehp 06/16/18 08:09:06 PM
#84398   I'd say they managed to get their act purplehp 06/16/18 08:06:52 PM
#84397   A blessing, actually. PINKribbon 06/16/18 08:04:06 PM
#84396   lol “....To be honest I felt he lost PINKribbon 06/16/18 07:53:55 PM
#84395   Transplants are a thing - you know it purplehp 06/16/18 07:53:11 PM
#84394   Yeah, I read that the other day...made me wonder. PINKribbon 06/16/18 07:50:33 PM
#84393   Indeed! When all other companies go alginate if purplehp 06/16/18 07:50:22 PM
#84392   I was touched by it and hope our Brian903 06/16/18 07:43:21 PM
#84391   Luckily for a few there is a miracle. purplehp 06/16/18 07:40:14 PM
#84390   Medicine for her diabetes kept her alive -- Brian903 06/16/18 07:31:27 PM
#84389   JKLM I like your posts and I think longboarder7892 06/16/18 03:12:39 PM
#84388   I think kw was exhausted by all the setbacks 1234jklm 06/16/18 02:18:26 PM
#84387   i forgot/ for convention/$PMCB/ you in san diego ????? mick 06/16/18 12:33:14 PM
#84386   it did/ $pmcb mick 06/16/18 12:31:58 PM
#84385   Well, that must have been Eurofins' burden. purplehp 06/16/18 10:49:34 AM
#84384   There is indeed a huge change. Now that purplehp 06/16/18 10:45:26 AM
#84383   Agreed Gmc2020 06/16/18 09:17:22 AM
#84382   What a waste ! During my career, I rcstock 06/16/18 08:43:35 AM
#84381   Mr. Morell is prepared to place PharmaCyte in 1234jklm 06/16/18 08:20:59 AM
#84380   I don’t have a lot of experience in Wolfy3 06/16/18 07:17:25 AM
#84379   The greatest achievement this year 1234jklm 06/15/18 11:07:50 PM
#84378   Purple isn’t it impressive that pmcb is managing 1234jklm 06/15/18 09:55:11 PM
#84377   I understand that. But is it enough or purplehp 06/15/18 08:45:09 PM
#84376   Going serum free is a requirement to market Wolfy3 06/15/18 08:22:14 PM
#84375   So I took the time to read, thoroughly, purplehp 06/15/18 07:36:30 PM
#84374   Yeah Ray, Looking forward to the actual party efood_dude 06/15/18 03:58:20 PM
#84373   I found it recently as well- I like Brian903 06/15/18 03:38:58 PM
#84372   Pete, I sincerely hope you are right. But iwitness4jc 06/15/18 03:14:53 PM
#84371   Looked over it twice it. PINKribbon 06/15/18 02:50:40 PM
#84370   Thank you and hope her surgery went well today $Pistol Pete$ 06/15/18 12:20:50 PM
#84369   Probably 3 weeks and coming back with IND submitted $Pistol Pete$ 06/15/18 12:20:06 PM
#84368   couple wks ????? mick 06/15/18 11:51:38 AM
#84367   He means the radio interview. It’s not 1234jklm 06/15/18 11:46:59 AM
#84366   ah little operation prayer for peter's mom and mick 06/15/18 11:24:53 AM